ArticleAging2023

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma.

Bidong Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.